Home > Products > CTLA4 & PD1 > Anti-CTLA4 x Anti-PD1 Bispecific Antibody (IgG-IgG)

Anti-CTLA4 x Anti-PD1 Bispecific Antibody (IgG-IgG)  (CAT#: BSIG-146)

Anti-CTLA4 x Anti-PD1 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CTLA4 and anti-PD1 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind two factors simultaneously and enhance immune response. It is designed for the research of Tumors therapy.
Datasheet INQUIRY

Specifications

Targets
CTLA4 & PD1
Type
IgG-IgG
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Tumors

Targets

Target 1
CTLA4
Gene ID
UniProt ID
Alternative Names
CTLA4; cytotoxic T-lymphocyte-associated protein 4; CD; GSE; GRD4; ALPS5; CD152; CTLA-4; IDDM12; CELIAC3; cytotoxic T-lymphocyte protein 4; CD152 isoform; celiac disease 3; insulin-dependent diabetes mellitus 12; cytotoxic T-lymphocyte-associated serine esterase-4; cytotoxic T lymphocyte associated antigen 4 short spliced form; ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4
Target 2
PD1
Gene ID
UniProt ID
Alternative Names
PDCD1; programmed cell death 1; PD1; PD-1; CD279; SLEB2; hPD-1; hPD-l; hSLE1; programmed cell death protein 1; protein PD-1; systemic lupus erythematosus susceptibility 2
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CTLA4 & PD1"
See other bsAb targets related to "PD1"

See other bsAb targets related to "CTLA4"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CTLA4 x Anti-PD1 Bispecific Antibody (IgG-IgG) (BSIG-146). Click the button below to contact us or submit your feedback about this product.